UNS:Role of Cell-Mediated ECM Remodeling in Pluripotent Stem Cell Differentiation
UNS:Role of Cell-Mediated ECM Remodeling in Pluripotent Stem Cell Differentiation
批准号:
1508950
负责人:
Sean Palecek
金额:
$35.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-06-01 至 2020-05-31
中文摘要
1508950帕莱切克,肖恩· 阻碍实现人类多能干细胞(hPSC)的前景的一个重要障碍是无法从hPSC有效地生物制造正常细胞,这在很大程度上是由于对hPSC如何决定如何分化为更特化的细胞类型的不完全理解。 这些细胞命运决定受到细胞环境中存在的化学和机械信号的影响。该项目将研究细胞外基质(ECM)环境的细胞重塑如何影响分化为各种试验台谱系,包括心脏细胞,血管细胞,脑细胞和皮肤细胞。这种对干细胞分化机制的更深入理解将为设计更有效、更明确的方案提供信息,以引导干细胞成为所需谱系的细胞。 因此,该项目的成果将对在实验室规模或生物制造应用中生产干细胞衍生的细胞和组织产生直接影响。该项目将验证hPSC在分化过程中细胞外基质重塑是干细胞分化命运的关键调节因子的假设。 该项目将确定通过ECM重塑调节hPSC命运的新的自分泌/旁分泌机制,并证明设计在hPSC分化期间增强或抑制ECM重塑的材料和支架的重要性。 为了检验这一假设,将使用蛋白质组学分析来鉴定在hPSC定向分化为心肌细胞、内皮细胞、神经元和角质形成细胞期间产生的ECM组分。 这些实验将鉴定调节特定hPSC分化命运的候选细胞合成的ECM蛋白。为了测试ECM合成对于有效定向分化是必要的预测,将采用CRISPR/Cas9介导的ECM基因敲除实验来评估抑制基质产生如何影响hPSC分化为心肌细胞、血管内皮细胞、神经元和角质形成细胞。 最后,为了检验经由ECM的蛋白水解降解的基质重塑影响hPSC分化效率的假设,将在定向分化期间监测基质金属蛋白酶表达和活性,然后将使用化学抑制剂和遗传敲除来定量这些蛋白酶在定向分化期间的贡献。 本提案中描述的教育和推广活动还将培训研究生和本科生水平的干细胞工程师,并将向K-12学生、K-12教师、本科生和公众提供技术、伦理、干细胞科学和工程的政治方面。这个由CBET生物技术和生物化学工程项目颁发的奖项是共同的,由材料研究部的生物材料计划资助。
英文摘要
1508950Palecek, Sean P. A significant roadblock impeding realization of the promise of human pluripotent stem cells (hPSCs) is the inability to efficiently biomanufacture normal cells from hPSCs, in a large part resulting from an incomplete understanding of how hPSCs decide how to differentiate to more specialized cell types. These cell fate decisions are influenced by chemical and mechanical signals present in the cell environment. This project will investigate how cell remodeling of their extracellular matrix (ECM) environment affects differentiation to various testbed lineages including heart cells, blood vessel cells, brain cells, and skin cells. This deeper understanding of mechanisms of stem cell differentiation will then inform design of more efficient, defined protocols for guiding stem cells to cells in desired lineages. Thus, the project outcomes will have direct implications on producing stem cell-derived cells and tissues at lab scale or in biomanufacturing applications.This project will test the hypothesis that extracellular matrix remodeling by hPSCs during differentiation is a key regulator of stem cell differentiation fate. The project will identify novel autocrine/paracrine mechanisms of regulation of hPSC fate via ECM remodeling, and demonstrate the importance of designing materials and scaffolds that enhance or inhibit ECM remodeling during hPSC differentiation. To test this hypothesis, proteomic analysis will be used to identify ECM components produced during hPSC directed differentiation to cardiomyocytes, endothelial cells, neurons, and keratinocytes. These experiments will identify candidate cell-synthesized ECM proteins that regulate specific hPSC differentiation fates. To test the prediction that ECM synthesis is necessary for efficient directed differentiation, CRISPR/Cas9-mediated ECM gene knockout experiments will be employed to assess how inhibiting matrix production affects hPSC differentiation to cardiomyocytes, vascular endothelial cells, neurons, and keratinocytes. Finally, to test the hypothesis that matrix remodeling via proteolytic degradation of ECM affects hPSC differentiation efficiency, matrix metalloprotease expression and activity will be monitored during directed differentiation, then chemical inhibitors and genetic knockouts will be used to quantify the contributions of these proteases during directed differentiation. Education and outreach activities described in this proposal will also train stem cell engineers at the graduate and undergraduate levels, and will provide outreach to K-12 students, K-12 teachers, undergraduate students, and the general public on technical, ethical, and political aspects of stem cell science and engineering.This award by the Biotechnology and Biochemical Engineering Program of CBET is co-funded by the Biomaterials Program of the Division of Materials Research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RECODE: Single Cell-Level Programming of Human Induced Pluripotent Stem Cell Directed Differentiation to Chamber-Specific Cardiomyocytes
-
批准号:2225300
-
项目类别:Standard Grant
-
资助金额:$150.0万
-
财政年份:2022
-
负责人:Sean Palecek
-
依托单位:
Integrated Manufacturing of Therapeutic Cardiac Cells
-
批准号:1743346
-
项目类别:Standard Grant
-
资助金额:$59.94万
-
财政年份:2017
-
负责人:Sean Palecek
-
依托单位:
EAGER: Biomanufacturing: Engineering Cell-Intrinsic Control of Cardiomyocyte Differentiation in Human Pluripotent Stem Cells
-
批准号:1547225
-
项目类别:Standard Grant
-
资助金额:$30.0万
-
财政年份:2015
-
负责人:Sean Palecek
-
依托单位:
Paradigm for Optimizing Stem Cell Differentiation
-
批准号:1066311
-
项目类别:Standard Grant
-
资助金额:$33.99万
-
财政年份:2011
-
负责人:Sean Palecek
-
依托单位:
EFRI-CBE: Regulating human embryonic stem cell differentiation via the mechanical microenvironment
-
批准号:0735903
-
项目类别:Standard Grant
-
资助金额:$200.0万
-
财政年份:2007
-
负责人:Sean Palecek
-
依托单位:
CAREER: A Cell-Based Biosensor for DNA Damaging Agents
-
批准号:0238680
-
项目类别:Continuing Grant
-
资助金额:$40.0万
-
财政年份:2003
-
负责人:Sean Palecek
-
依托单位:
NER: Surface Assembly of Functional Protein Nanosensors
-
批准号:0103348
-
项目类别:Standard Grant
-
资助金额:$7.15万
-
财政年份:2001
-
负责人:Sean Palecek
-
依托单位:
海外基金